Updated Jul 16, 2026 · Last SEC filing 2026-06-23
Adicet Bio, Inc. (ACET) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-23. 3 Form 8-K material event filings were reported by ACET in the last 90 days. InsiderAlpha tracks every ACET SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001720580 |
| Form 4 filings (90d) | 9 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Latest Form 4 filing | 2026-06-23 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Insider | J — Other acquisition / disposition | 250.0K | — | — | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 32.5K | $6.29 | $205K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 40.4K | $6.52 | $264K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 29.3K | $6.53 | $191K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | S — Open-market sale | 2.4K | $6.38 | $15K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 74.8K | $7.27 | $543K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 74.3K | $7.21 | $535K | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | P — Open-market purchase | 74.6K | $7.04 | $525K | SEC | |
| Schor Chen | President & CEO | F — Tax withholding / forfeiture | 1.8K | $8.44 | $15K | SEC | |
| Harvey Brian Nicholas | Chief Financial Officer | F — Tax withholding / forfeiture | 546 | $8.44 | $5K | SEC | |
| Aftab Blake | Chief Scientific Officer | F — Tax withholding / forfeiture | 535 | $8.44 | $5K | SEC | |
| Healey Don | Chief Technology Officer | F — Tax withholding / forfeiture | 535 | $8.44 | $5K | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | P — Open-market purchase | 3.50M | $1.00 | $3.50M | SEC | |
| ORBIMED ADVISORS LLC | 10% Owner | P — Open-market purchase | 1.50M | $1.00 | $1.50M | SEC | |
| DUBIN STEVE | Insider | A — Grant or award | 5.9K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Adicet Bio, Inc. (ACET). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 2 | — |
| Peng Katie | 1 | — |
| DUBIN STEVE | 1 | — |
| Aftab Blake | 1 | — |
| Schor Chen | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ACET insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ACET dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.